NCT01490762View on ClinicalTrials.gov

Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

July 31, 2012

Conditions
Healthy
Interventions
DRUG

Technosphere Insulin Inhalation Powder using the Gen2C inhaler

Inhalation Powder

DRUG

Regular Human Insulin

Subcutaneous injection

Trial Locations (1)

91911

Profil Institute for Clinical Research, Chula Vista

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY